Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 4, 1996, Pages 747-752

  Pryhuber, Keith G ^b   Murray, Kevin J ^b   Donnelly, Patricia ^b   Passo, Murray H ^b   Maksymowych, Walter P ^b   Glass, David N ^b   Giannini, Edward H ^b   Colbert, Robert A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

HLA B27; Juvenile rheumatoid arthritis; LMP2; Proteasome gene

Indexed keywords

HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; ARTHRITIS, JUVENILE RHEUMATOID; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CYSTEINE ENDOPEPTIDASES; DISEASE SUSCEPTIBILITY; GENES, MHC CLASS II; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEINS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0029972701     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nepom B: The immunogenetics of juvenile rheumatoid arthritis. In: Athreya BH. ed. Rheumatic Disease Clinics of North America. Philadelphia: WB Saunders, 1991:825-42.
2. Fernandez-Vina M, Fink CW, Stastny P: HLA associations in juvenile arthritis. Clin Exp Rheum 1994;12 205-14.
3. Rachelefsky GS, Terasaki PI, Katz R, Stiehm ER: Increased prevalence of W27 in juvenile rheumatoid arthritis. New Engl J Med 1974;290:892-3.
4. Edmonds J, Morris RI, Metzger AL, et al. Follow-up study of juvenile chronic polyathritis with particular references to histocompatibility antigen W.27. Ann Rheum Dis 1974;33:289-92.
5. Akiyama K, Yokota K, Kagawa S, et al: cDNA cloning and Interferon γ down-regulaton of proteasomal subunits X and Y. Science 1994;265:1231-3.
6. Driscoll J, Brown MG, Finley D, Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993;365:262-4.
7. Gaczynska M, Rock KL, Goldberg AL. γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993;365:264-7.
8. Zhou P, Cao H, Smart M, David C: Molecular basis of genetic polymorphism in major histocompatibility complex-linked proteasome gene (LMP-2). Proc Natl Acad Sci USA 1993;90:2681-4.
9. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO: HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T lymphocytes. J Virology 1989;63:1756-62.
10. Nuchtern JG, Biddison WE, Klausner RD: Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990;343:74-6